SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
QCOR Questcor Pharmaceutical
An SI Board Since June 2011
Posts SubjectMarks Bans Symbol
107 13 0 QCOR
Emcee:  Savant Type:  Moderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
107 Mallinckrodt Boosts Guidance as Loss NarrowsBy Michael Calia Savant-8/7/2014
106 Questcor Enters Into Development Collaboration Agreement Covering NoSavant-5/14/2014
105 Mallinckrodt Pharmaceuticals and Questcor Pharmaceuticals Announce ESavant-5/12/2014
104 Questcor Pharma 1Q Adj EPS $1.40 >QCORQuestcor Reports FirSavant-4/28/2014
103 Questcor to Report First Quarter Financial Results on April 28, 2014Savant-4/24/2014
102 Mallinckrodt to Buy Questcor for $5.6 Billion -- UpdateBy Jonathan Savant-4/7/2014
101Divvies... a tax on shorts...sense-1/28/2014
100This prolly helped the Jan pps increase..Questcor Pharmaceuticals, Inc. (Savant-1/28/2014
99They've been dramatically short this thing since below $4... Which mostly ssense-1/28/2014
98 Questcor Pharma rebounds from after-hours lows, but still -3% on comSavant-12/19/2013
97fwiw, QCOR bounced up from 200 Day SMA, which also filled the gap up from July 3Savant-12/13/2013
96Questcor Announces Quarterly Cash Dividend and Provides Update on Share Savant-12/11/2013
95 Questcor Honored as an "Everyday Hero" by NephCure FoundatSavant-11/27/2013
94 Questcor Reports Third Quarter Financial ResultsQuestcor RepoSavant-10/30/2013
93 Questcor To Commence Phase 2 Study of Acthar for Acute Respiratory DSavant-10/22/2013
92Questcor Pharmaceuticals Inc. (QCOR) increased its quarterly dividSavant-10/17/2013
91Questcor 2nd-Quarter Net Up 67% on Increased Acthar Adoption By Kristin Jones QSavant-7/31/2013
90Questcor to Commence Phase 2 Study of Acthar for ALS ANAHEIM, Calif., July 24, 2Savant-7/25/2013
89Questcor to Report Second Quarter Financial Results on July 30, 2013 ANAHEIM,Savant-7/12/2013
88Questcor to Initiate Pilot Commercialization Effort In Pulmonology for SymptomatSavant-7/11/2013
87So much for the "threat" of competitors making synthetics... "Usense-6/26/2013
86fwiw; i am fully out now. this last bit was a wonderful surprise.mopgcw-6/12/2013
85Questcor Pharmaceuticals Acquires Rights to Synacthen(R) - Expands Questcor'Savant-6/11/2013
84UnitedHealth (UNH) Now Covering Questcor's (QCOR) Actharmopgcw-6/7/2013
83Questcor Pharmaceuticals Announces Quarterly Dividend ANAHEIM, Calif., May 29Savant-5/29/2013
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News